The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression

2003/04/23 by A. John Rush, A.John Rush, Madhukar H. Trivedi +22 · 3,914 citations
Medicine · Psychology · #Clinical psychology #Cronbach's alpha #Depression (economics) #Developmental psychology #Mental Health Research Topics #Mental Health Treatment and Access #Psychiatry #Psychology #Psychometrics #Rating scale #Treatment of Major Depression

paper · doi:10.1016/s0006-3223(02)01866-8

published in Biological Psychiatry 54(5), 573-583 (Elsevier BV)

openalex publication_date 2003/04/23 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/05

Cited by

• A Randomized Trial of Citalopram versus Placebo in Outpatients with Asthma and Major Depressive Disorder: A Proof of Concept Study
• Detecting Bipolar Depression From Geographic Location Data
• Assessment of mood: Guides for clinicians
• Antidepressant effects of selective slow wave sleep deprivation in major depression: A high-density EEG investigation
• Interpersonal Counseling (IPC) for Depression in Primary Care
• The equivalence of psychodynamic therapy and cognitive behavioral therapy for depressive disorders in adults: A meta‐analytic review
• Treating insomnia improves mood state, sleep, and functioning in bipolar disorder: A pilot randomized controlled trial.
• Antidepressant medications in dementia: evidence and potential mechanisms of treatment-resistance
• Digital questionnaire response time (DQRT): A ubiquitous and low-cost digital assay of cognitive processing speed
• Psychosocial Correlates of Social Withdrawal in Adolescent Psychiatric Outpatients: The Role of Resilience and Modern-Type Depression Traits
• Real-time optimization to enhance noninvasive cortical excitability assessment in the human dorsolateral prefrontal cortex
• gLOP: the global and Local Penalty for Capturing Predictive Heterogeneity
• Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up
• Learning Bayesian Networks from Ordinal Data
• Cognitive sequences in obsessive-compulsive disorder are supported by frontal cortex ramping activity
• Media experiences and associations with mental health among the bereaved of the MH17‐disaster: A latent profile analysis
• Big Data Analytics and AI in Mental Healthcare
• A Primer on the Signature Method in Machine Learning
• Variable Selection in Regression-based Estimation of Dynamic Treatment Regimes
• Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication
• Undoing death: Counterfactual thinking and emotional adaptation to bereavement
• A common symptom geometry of mood improvement under sertraline and placebo associated with distinct neural patterns
• A review of depression and suicide risk assessment using speech analysis
• Cognitive Behavioral Therapy to Sustain the Antidepressant Effects of Ketamine in Treatment-Resistant Depression: A Randomized Clinical Trial
• An analysis of daily 10 Hz and accelerated theta burst transcranial magnetic stimulation on suicidality in treatment resistant depression
• Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression
• Caregiver depression: The contributing role of depression in patients, stigma, social support and religiosity
• Statistical harmonization corrects site effects in functional connectivity measurements from multi‐site fMRI data
• The Transdiagnostic Connectome Project: an open dataset for studying brain-behavior relationships in psychiatry
• Prolonged grief symptoms and lingering attachment predict approach behavior toward the deceased
• Network meta-analysis of the effectiveness of psychotherapies with or without medication for treating adult depression
• Depression is not a consistent syndrome: An investigation of unique symptom patterns in the STAR*D study
• Effectiveness of electroconvulsive therapy for depression: comparing research studies with real-world clinical data from the Dutch ECT consortium
• Effect of AI-Based Natural Language Feedback on Engagement and Clinical Outcomes in Fully Self-Guided Internet-Based Cognitive Behavioral Therapy for Depression: 3-Arm Randomized Controlled Trial
• Predicting Relapse of Depressive Episodes During Maintenance Treatment: The Canadian Biomarker Integration Network in Depression (CAN-BIND) Wellness Monitoring in Major Depressive Disorder Study: Prédire la rechute d’épisodes dépressifs pendant le traitement d’entretien : Une étude de suivi du bien-être dans les troubles dépressifs majeurs du Réseau canadien d’intégration des biomarqueurs pour la dépression (CAN-BIND)
• Estimates of the minimal important difference to evaluate the clinical significance of antidepressants in the acute treatment of moderate-to-severe depression
• Effects of daylight on sleep and circadian rhythms in patients with depression
• Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology
• Differences in High-Frequency Connectivity Among Large-Scale Functional Networks Linked to Major Depressive Disorder and Treatment-Resistant Depression
• A Comprehensive Review of Datasets for Clinical Mental Health AI Systems
• Durability of the benefit of vagus nerve stimulation in markedly treatment-resistant major depression: a RECOVER trial report
• Application of the Signature Method to Pattern Recognition in the CEQUEL Clinical Trial
• Prolonged Grief Symptoms Predict Social and Emotional Loneliness and Depression Symptoms
• Increased serum levels of leptin and insulin in both schizophrenia and major depressive disorder: A cross-disorder proteomics analysis
• Effectiveness of a Guided Internet- and Mobile-Based Intervention for Patients with Chronic Back Pain and Depression (WARD-BP): A Multicenter, Pragmatic Randomized Controlled Trial
• Deriving information from missing data: implications for mood prediction
• The Contribution of Adverse Childhood Experiences and Neighborhood Characteristics on Outcomes Experienced by Urban Dwelling Black Men After Serious Traumatic Injury
• Detecting early signs of depressive and manic episodes in patients with bipolar disorder using the signature-based model
• Examining multiple features of episodic future thinking and episodic memory among suicidal adults
• Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial
• ElectroConvulsive therapy Cognitive Assessment (ECCA) tool: A new instrument to monitor cognitive function in patients undergoing ECT
• Daily longitudinal self-monitoring of mood variability in bipolar disorder and borderline personality disorder
• Hypersomnia as a predictor of response to intravenous ketamine/intranasal esketamine in treatment resistant depression
• Baseline perceived stress as a predictor of ketamine/esketamine treatment response in treatment-resistant depression
• Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
• Development and psychometric evaluation of the Yale–Brown Obsessive-Compulsive Scale—Second Edition.
• Towards automated symptoms assessment in mental health
• Body Dissatisfaction and Mental Health Outcomes of Youth on Gender-Affirming Hormone Therapy
• Substance use in youth at risk for psychosis
• Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial
• A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials
• Clinical use of the Hamilton Depression Rating Scale: is increased efficiency possible? A post hoc comparison of Hamilton Depression Rating Scale, Maier and Bech subscales, Clinical Global Impression, and Symptom Checklist-90 scores
• Depression Detection Using Digital Traces on Social Media: A Knowledge-aware Deep Learning Approach
• Switching Antidepressants After a First Selective Serotonin Reuptake Inhibitor in Major Depressive Disorder
• Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study
• Lifetime and 12-Month Prevalence of Bipolar Spectrum Disorder in the National Comorbidity Survey Replication
• Insomnia in Patients with Depression
• High-risk behaviour in hypomanic states
• The clinical characterization of the adult patient with depression aimed at personalization of management
• Preserving Subjective Wellbeing in the Face of Psychopathology: Buffering Effects of Personal Strengths and Resources
• HowNutsAreTheDutch (HoeGekIsNL): A crowdsourcing study of mental symptoms and strengths
• Temporal Dynamics of Health and Well-Being: A Crowdsourcing Approach to Momentary Assessments and Automated Generation of Personalized Feedback
• Q- and A-Learning Methods for Estimating Optimal Dynamic Treatment Regimes
• Lamotrigine Therapy for Bipolar Depression: Analysis of Self-Reported Patient Data
• Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines
• Practical tools for female-specific ADHD: The impact of hormonal fluctuations in clinical practice and from the literature
• An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report. [europepmc]
• Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. [europepmc]
• Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. [europepmc]
• Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. [europepmc]
• Race and financial strain are independent correlates of sleep in midlife women: the SWAN sleep study. [europepmc]
• The importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment research. [europepmc]
• Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. [europepmc]
• Age differences in major depression: results from the National Comorbidity Survey Replication (NCS-R). [europepmc]
• Age differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: results from the WHO World Mental Health Survey Initiative. [europepmc]
• Depression care in the United States: too little for too few. [europepmc]
• Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. [europepmc]
• Harnessing context sensing to develop a mobile intervention for depression. [europepmc]
• Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms. [europepmc]
• Prefrontal atrophy, disrupted NREM slow waves and impaired hippocampal-dependent memory in aging. [europepmc]
• Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. [europepmc]
• Depression is not a consistent syndrome: An investigation of unique symptom patterns in the STAR*D study. [europepmc]
• Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology. [europepmc]
• Transcranial direct current stimulation for acute major depressive episodes: meta-analysis of individual patient data. [europepmc]
• Harmonization of cortical thickness measurements across scanners and sites. [europepmc]
• Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial. [europepmc]
• Statistical harmonization corrects site effects in functional connectivity measurements from multi-site fMRI data. [europepmc]
• The clinical characterization of the adult patient with depression aimed at personalization of management. [europepmc]
• Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. [europepmc]
• Landscapes of bacterial and metabolic signatures and their interaction in major depressive disorders. [europepmc]
• The mental health impact of the COVID-19 pandemic on people with and without depressive, anxiety, or obsessive-compulsive disorders: a longitudinal study of three Dutch case-control cohorts. [europepmc]